BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 125896
Published online Nov 24, 2026. doi: 10.5306/wjco.125896
Table 1 Key evidence supporting the sympathetic nerve-cancer-associated fibroblast feedback loop model in pancreatic ductal adenocarcinoma
Level of evidence Support
Evidence type
Experimental model
Directness of evidence
Cell
Receptor/signals
Interventions
Outcomes
Stromal/neural output
Unresolved question
Ref.
EstablishedA/B/C/DKPC mice/human PDAC tissueDirectUnclearβ2-ARTrk inhibitor and gemcitabine/Nonselective β-BlockerSurvival of PDAC mice and patients/tumor sizePancreatic nerve densityβ2-AR expression differs among CAFs and tumors[6]
EstablishedA/B/C/DGenetic sympathectomy KPC mice/human PDAC tissueDirectiCAF/ECMIL-6/JAK/STAT3Diphtheria toxin-inducible sympathectomyNeuro-associated survival trends in patientsAxon extensionUnderestimate the extent of bidirectional transcriptional regulation[7]
EstablishedB/C/DOrthotopic Transplantation Mouse Models/KPC mice/human PDAC tissueDirectmyCAFTGFβ1/SEMA7A; α1-AR/ERK, CREBChemical Sympathectomy/conditional Gαq-coupled hM3Dq designer receptor exclusively activated by designer drugsFibrosis and neoplastic expansionRecruitment of sympathetic nervesRequires further validation in patient-derived systems before translation to human PDAC[8]
Partially supportedC/DPancreatic cancer cells invade the sciatic nerveIndirectPancreatic cancer cellsNE/STAT3/NGF/MMP2/MMP9Block β-adrenergic receptors/block protein kinase ANeural invasionPancreatic cancer cell migration, invasion, and neural invasionExamine the clinical relevance[15]


Write to the Help Desk